Umbra Companies Inc (ZEOX)

Zeo ScientifiX Inc (ZEOX) is a common stock listing on OTC Markets associated with Zeo ScientifiX, Inc., a healthcare company focused on biotechnology. The company is clinical-stage and works on biological therapeutics aimed at degenerative diseases and regenerative medicine. Its lead candidate, Zofin, is an acellular biologic derived from perinatal sources and is being studied in Phase I/II trials for conditions including COVID-19, chronic obstructive pulmonary disease, osteoarthritis, and traumatic brain injury. Zeo ScientifiX also develops Patient Pure X, an autologous biologic intended to support tissue healing and reduce inflammation, along with topical aesthetic products such as ZEO GROWX, ZEO HAIR GROW, and ZEO GROW BOOST. The company maintains a strategic collaboration with Regen Therapy Limited and was incorporated in 2011. It is based in Davie, Florida, and formerly operated under the name Organicell Regenerative Medicine, Inc.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-ZEOX
Not available
Not available
Not available
Fair
0.0%
September 22, 2026
15.0x
1.5x
10.816 M
9.156 M
75.1%
47.4%
-26.4
34.8%
Valuation • Fair Value

Umbra Companies Inc (OTC-ZEOX) Fair Value by Valuation Model

Review the available estimates for Umbra Companies Inc (OTC-ZEOX), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

DCF Fair Value

$1.22

Discounted cash flow valuation reference.

Comps Fair Value

$1.27

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 2 available valuation references for Umbra Companies Inc (OTC-ZEOX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Umbra Companies Inc (OTC-ZEOX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.987 M

Current operating scale indicator.

Revenue Forecast

5.589 M

Forward revenue estimate.

EBITDA

-4.052 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Umbra Companies Inc (OTC-ZEOX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Umbra Companies Inc (OTC-ZEOX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

1,000.00

Higher caution zone on this screen.

Altman Z-Score

-26.4

Lower score that deserves closer risk review.

FCF / Net Income

34.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Umbra Companies Inc (OTC-ZEOX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Umbra Companies Inc (OTC-ZEOX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

September 22, 2026

Days to Earnings

4

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Umbra Companies Inc (OTC-ZEOX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Umbra Companies Inc (OTC-ZEOX) Stock Forecast & Technical Outlook

Review Umbra Companies Inc (OTC-ZEOX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Umbra Companies Inc (OTC-ZEOX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Umbra Companies Inc (OTC-ZEOX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Umbra Companies Inc (OTC-ZEOX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Umbra Companies Inc (OTC-ZEOX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Umbra Companies Inc (OTC-ZEOX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Umbra Companies Inc (OTC-ZEOX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Umbra Companies Inc (OTC-ZEOX) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Umbra Companies Inc (OTC-ZEOX) Stock FAQ

Data-supported answers about Umbra Companies Inc (OTC-ZEOX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Umbra Companies Inc (OTC-ZEOX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Umbra Companies Inc (OTC-ZEOX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Umbra Companies Inc (OTC-ZEOX) is September 22, 2026.

The latest available data indicates no current dividend yield for Umbra Companies Inc (OTC-ZEOX).

The current market capitalization listed for Umbra Companies Inc is 10.816 M.

The current enterprise value listed for Umbra Companies Inc is 9.156 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Umbra Companies Inc is OTC-ZEOX, and the stock is listed on OTC Markets.

Umbra Companies Inc (OTC-ZEOX) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Umbra Companies Inc is 75.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Umbra Companies Inc is 47.4%. Free float helps investors understand how much of the share base is available for public trading.